Rut Andrea

Grup de recerca

Aterosclerosi, malaltia coronària i insuficiència cardíaca Accredited researcher (R3A)

randrea@clinic.cat 0000-0002-8409-5013

Segueix-lo/a a:

El compte de twitter de Rut . Aquest enllaç s'obre en una nova pestanya.

Publicacions destacades

Prognosis of new-onset heart failure outpatients and collagen biomarkers

Autors:
Sanchis, L; Andrea, R; Falces, C; Llopis, J; Morales-Ruiz, M;

López-Sobrino, T; Pérez-Villa, F; Sitges, M; Sabate, M; Brugada, J.

Referència: European Journal Of Clinical Investigation 2015.
Transfemoral transcatheter aortic valve replacement compared with surgical replacement in patients with severe aortic stenosis and comparable risk: Cost-utility and its determinants

Autors:
Ribera, A; Slof, J; Andrea, R; Falces, C; Gutiérrez, E;

(...)

Serra, V; García-del Blanco, B; Tornos, P; Garcia-Dorado, D; Ferreira-González, I.

Referència: International Journal Of Cardiology 2015.
Lung Function Abnormalities are Highly Frequent in Patients with Heart Failure and Preserved Ejection Fraction

Autors:
Andrea, R; López-Giraldo, A; Falces, C; Sobradillo, P; Sanchis, L;

Gistau, C; Heras, M; Sabate, M; Brugada, J; Agustí, A.

Referència: Heart Lung And Circulation 2014.
Inter-atrial dyssynchrony contributes to heart failure symptoms in patients with preserved ejection fraction: a potential novel therapeutic target

Autors:
Vannini, L; Gabrielli, L; Bijnens, B; Sanchis, L; Duchateau, N;

Andrea, R; Falces, C; Morales, M; Sitges, M.

Referència: European Heart Journal 2013.
[Diagnosis of heart failure with preserved or reduced ejection fraction in a stop clinic]

Autors:
Andrea, R; Falces, C; Sanchis, L; Sitges, M; Heras, M;

Brugada, J.

Referència: Atencion Primaria 2013.
Percutaneous transcatheter aortic valve implantation: present and future perspective

Autors:
Fernández, D; Cevallos, J; Brugaletta, S; Martín-Yuste, V; Freixa, X;

Andrea, R; Falces, C; Regueiro-Cueva, A; Masotti, M; Sabaté, M.

Referència: Expert Review Of Medical Devices 2013.
Bioprosthesis dysfunction as a presentation form of Coxiella burnettii endocarditis

Autors:
Santiago, E; Andrea, R; Del Río, A; Mestres, CA;

Referència: Rev Clin Esp 2013.
Monitoring Chronic Patients Between Primary Care and Cardiology. Response

Autors:
Falces, C; Andrea, R;

Referència: Rev Esp Cardiol 2012.
Integration Between Cardiology and Primary Care: Impact on Clinical Practice

Autors:
Falces, C; Andrea, R; Heras, M; Vehí, C; Sorribes, M;

(...)

Menacho, I; Porcar, S; Font, D; Sabaté, M; Brugada, J.

Referència: Rev Esp Cardiol 2011.
Current foundations of the pharmacological treatment of ischemic heart disease

Autors:
Andrea, R; Bellera, N; Loma-Osorio, P;

Referència: Rev Esp Cardiol 2006.

Projectes destacats

HORIZONS 2020. Clinical Trial: EURO SHOCK trial. European Union's Horizon 2020 research and innovation programme under grant agreement No. 754946.

Investigador/a principal: Manel Sabate Tenas

Finançador: HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA (Sede o evento)

Durada: 01/01/2019
HORIZONS 2020. Protocol number 633765. EudraCT Number 2015-002868-17.Secondary prevention of cardiovascular disease in the elderly population (SECURE)

Investigador/a principal: RUT ANDREA

Finançador: HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA (Sede o evento); Horizon 2020

Durada: 01/01/2017 - 31/10/2021
FIS PI15/00553: Acute myocardial infarction in young patients. Analysis of prothrombotic, inflammatory and epigenic factors. Effect of miRNA expression modulation in a porcine model.

Investigador/a principal: RUT ANDREA

Finançador: HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA (Sede o evento); Instituto de Salud Carlos III

Durada: 01/01/2015 - 01/01/2018
FIS PI15/00837: Comparación aleatoria entre una estrategia de intervención sobre fragilidad frente a estrategia habitual en pacientes frágiles después de un infarto agudo de miocardio

Investigador/a principal: RUT ANDREA RIBA

Finançador: Hospital Clínico Universitario de Valencia (Sede o evento); Instituto de Salud Carlos III

Durada: 01/01/2015 - 01/01/2018
FIS PI 13/01485 HIPOTERMIA TERAPÉUTICA Y RIESGO DE TROMBOSIS : ESTUDIO DE ACTIVIDAD PLAQUETARIA Y LA FUNCIÓN ENDOTELIAL

Investigador/a principal: RUT ANDREA

Finançador: HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA (Sede o evento); Instituto de Salud Carlos III

Durada: 01/01/2013 - 01/01/2016

Rut Andrea

Grup de recerca

Publicacions destacades

Inter-atrial dyssynchrony contributes to heart failure symptoms in patients with preserved ejection fraction: a potential novel therapeutic target

Projectes destacats

HORIZONS 2020. Clinical Trial: EURO SHOCK trial. European Union's Horizon 2020 research and innovation programme under grant agreement No. 754946.

HORIZONS 2020. Protocol number 633765. EudraCT Number 2015-002868-17.Secondary prevention of cardiovascular disease in the elderly population (SECURE)

FIS PI15/00553: Acute myocardial infarction in young patients. Analysis of prothrombotic, inflammatory and epigenic factors. Effect of miRNA expression modulation in a porcine model.

FIS PI15/00837: Comparación aleatoria entre una estrategia de intervención sobre fragilidad frente a estrategia habitual en pacientes frágiles después de un infarto agudo de miocardio

FIS PI 13/01485 HIPOTERMIA TERAPÉUTICA Y RIESGO DE TROMBOSIS : ESTUDIO DE ACTIVIDAD PLAQUETARIA Y LA FUNCIÓN ENDOTELIAL

Subscriu-te a la Newsletter del Clínic